Global Pharmacovigilance Market

Company Usability Profiles:

The global pharmacovigilance market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The global pharmacovigilance market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Accenture, Inc.
  • Bristol-Myers Squibb
  • Clinquest Group B.V.
  • Covance
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • ICON
  • iGATE Corporation
  • iMEDGlobal Corporation
  • inVentiv Health
  • Novartis International
  • PAREXEL International
  • Pfizer Inc.
  • Quanticate
  • Sciformix

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Market Segmentation & Coverage:

The research report categorizes the Global Pharmacovigilance Market to forecast the revenues and analyze the trends in each of the following segments:

  • GLOBAL PHARMACOVIGILANCE MARKET, BY CLINICAL TRIAL
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Pre-clinical
  • GLOBAL PHARMACOVIGILANCE MARKET, BY METHOD
    • Cohort Event Monitoring
    • EHR Mining
    • Intensified ADR Reporting
    • Spontaneous Reporting
    • Targeted Spontaneous Reporting
  • GLOBAL PHARMACOVIGILANCE MARKET, BY TYPE
    • Contract Outsourcing
    • In-house
  • GLOBAL PHARMACOVIGILANCE MARKET, BY END USER
    • Academic & Research Institutes
    • Government Agencies
    • Health Insurance Companies
    • Hospitals & Care Providers
  • GLOBAL PHARMACOVIGILANCE MARKET, BY GEOGRAPHY
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
    • Asia-Pacific
      • Australia
      • China
      • India
      • Japan
    • Europe, Middle East & Africa
      • France
      • Germany
      • Italy
      • Spain
      • United Kingdom

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Global Pharmacovigilance Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Global Pharmacovigilance Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Global Pharmacovigilance Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Global Pharmacovigilance Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Global Pharmacovigilance Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Global Pharmacovigilance Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Global Pharmacovigilance Market .
  • Evaluate the key vendors in the Global Pharmacovigilance Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
      1. Research Process
      2. Research Framework
      3. Research Reliability & Validity
      4. Research Assumptions
    2. Forecasting Methodology
    3. Research Outcome
      1. 360iResearch Competitive Strategic Window
        1. Leverage Zone
        2. Vantage Zone
        3. Speculative Zone
        4. Bottleneck Zone
      2. 360iResearch FPNV Positioning Matrix
        1. 360iResearch Quadrants
          1. Forefront
          2. Pathfinders
          3. Niche
          4. Vital
        2. Business Strategy
          1. Business Growth
          2. Industry Coverage
          3. Financial Viability
          4. Channel Support
        3. Product Satisfaction
          1. Value for Money
          2. Ease of Use
          3. Product Features
          4. Customer Support
  3. Executive Summary
    1. Outlook in the Pharmacovigilance Market
    2. Opportunities in the Pharmacovigilance Market
    3. Geographical Analysis in the Pharmacovigilance Market
  4. Premium Insight
    1. Market Connectivity
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    3. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    4. Industry Trends
  5. Global Pharmacovigilance Market, by Clinical Trial
    1. Overview
    2. Market Sizing & Forecasting
    3. Phase I
    4. Phase II
    5. Phase III
    6. Phase IV
    7. Pre-clinical
  6. Global Pharmacovigilance Market, by Method
    1. Overview
    2. Market Sizing & Forecasting
    3. Cohort Event Monitoring
    4. EHR Mining
    5. Intensified ADR Reporting
    6. Spontaneous Reporting
    7. Targeted Spontaneous Reporting
  7. Global Pharmacovigilance Market, by Type
    1. Overview
    2. Market Sizing & Forecasting
    3. Contract Outsourcing
    4. In-house
  8. Global Pharmacovigilance Market, by End User
    1. Overview
    2. Market Sizing & Forecasting
    3. Academic & Research Institutes
    4. Government Agencies
    5. Health Insurance Companies
    6. Hospitals & Care Providers
  9. Global Pharmacovigilance Market, by Geography
    1. Americas
      1. Overview
      2. Market Sizing & Forecasting
      3. Argentina
      4. Brazil
      5. Canada
      6. Mexico
      7. United States
    2. Asia-Pacific
      1. Overview
      2. Market Sizing & Forecasting
      3. Australia
      4. China
      5. India
      6. Japan
    3. Europe, Middle East & Africa
      1. Overview
      2. Market Sizing & Forecasting
      3. France
      4. Germany
      5. Italy
      6. Spain
      7. United Kingdom
  10. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix for Global Pharmacovigilance Market
    2. Market Vendor Ranking Analysis for Global Pharmacovigilance Market
    3. Competitive News Feed Analysis for Global Pharmacovigilance Market
  11. Company Usability Profiles
    1. Accenture, Inc.
      1. Overview
      2. Strategy
      3. SWOT
    2. Bristol-Myers Squibb
      1. Overview
      2. Strategy
      3. SWOT
    3. Clinquest Group B.V.
      1. Overview
      2. Strategy
      3. SWOT
    4. Covance
      1. Overview
      2. Strategy
      3. SWOT
    5. F. Hoffmann-La Roche
      1. Overview
      2. Strategy
      3. SWOT
    6. GlaxoSmithKline
    7. ICON
    8. Novartis International
    9. PAREXEL International
    10. Pfizer Inc.
    11. Quanticate
    12. Sciformix
    13. iGATE Corporation
    14. iMEDGlobal Corporation
    15. inVentiv Health
  12. Appendix
    1. Discussion Guide
    2. Top Reports
      1. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      2. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      3. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      4. Global Fitness App Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      5. Global A2P and P2A Messaging Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      6. Global PDF Editor Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
      7. Global Innovation Management Software Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
    3. Author Details

List of Tables

  1. GLOBAL PHARMACOVIGILANCE MARKET SIZE, 2016-2025 (USD MILLION)
  2. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  3. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  4. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE I, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE II, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE III, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PHASE IV, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY PRE-CLINICAL, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  9. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  10. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY COHORT EVENT MONITORING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY EHR MINING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  12. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY INTENSIFIED ADR REPORTING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  13. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY SPONTANEOUS REPORTING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  14. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TARGETED SPONTANEOUS REPORTING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  16. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CONTRACT OUTSOURCING, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  17. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY IN-HOUSE, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  18. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  19. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  20. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY GOVERNMENT AGENCIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  21. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HEALTH INSURANCE COMPANIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  22. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  23. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  24. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  25. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  26. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  27. AMERICAS PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  28. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  29. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  30. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  31. ARGENTINA PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  32. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  33. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  34. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  35. BRAZIL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  36. CANADA PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  37. CANADA PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  38. CANADA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  39. CANADA PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  40. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  41. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  42. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  43. MEXICO PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  44. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  45. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  46. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  47. UNITED STATES PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  48. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  49. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  50. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  51. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  52. ASIA-PACIFIC PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  53. AUSTRALIA PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  54. AUSTRALIA PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  55. AUSTRALIA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  56. AUSTRALIA PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  57. CHINA PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  58. CHINA PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  59. CHINA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  60. CHINA PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  61. INDIA PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  62. INDIA PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  63. INDIA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  64. INDIA PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  65. JAPAN PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  66. JAPAN PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  67. JAPAN PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  68. JAPAN PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  69. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  70. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  71. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  72. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  73. EUROPE, MIDDLE EAST & AFRICA PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  74. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  75. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  76. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  77. FRANCE PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  78. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  79. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  80. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  81. GERMANY PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  82. ITALY PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  83. ITALY PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  84. ITALY PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  85. ITALY PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  86. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  87. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  88. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  89. SPAIN PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  90. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2016-2025 (USD MILLION)
  91. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2016-2025 (USD MILLION)
  92. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2016-2025 (USD MILLION)
  93. UNITED KINGDOM PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2016-2025 (USD MILLION)
  94. GLOBAL PHARMACOVIGILANCE MARKET: RANKING
  95. GLOBAL PHARMACOVIGILANCE MARKET: BUSINESS STRATEGY
  96. GLOBAL PHARMACOVIGILANCE MARKET: PRODUCT SATISFACTION
  97. GLOBAL PHARMACOVIGILANCE MARKET: AUTHOR DETAILS

List of Figures

  1. Global Pharmacovigilance Market: Research Process
  2. Global Pharmacovigilance Market: Research Framework
  3. Global Pharmacovigilance Market: Forecasting Methodology
  4. Global Pharmacovigilance Market: 360iResearch Competitive Strategic Window
  5. Global Pharmacovigilance Market: 360iResearch FPNV Positioning Matrix
  6. GLOBAL PHARMACOVIGILANCE MARKET SIZE, 2016-2025 (USD MILLION)
  7. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  8. GLOBAL PHARMACOVIGILANCE MARKET: MARKET CONNECTIVITY
  9. PORTERS FIVE FORCES ANALYSIS FOR GLOBAL PHARMACOVIGILANCE MARKET
  10. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2018 VS 2025 (USD MILLION)
  11. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY CLINICAL TRIAL, 2025 (USD MILLION)
  12. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2018 VS 2025 (USD MILLION)
  13. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY METHOD, 2025 (USD MILLION)
  14. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2018 VS 2025 (USD MILLION)
  15. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY TYPE, 2025 (USD MILLION)
  16. GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2018 VS 2025 (USD MILLION)
  17. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACOVIGILANCE MARKET SIZE, BY END USER, 2025 (USD MILLION)
  18. GLOBAL PHARMACOVIGILANCE MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  19. ACCENTURE, INC.: BUSINESS SWOT
  20. BRISTOL-MYERS SQUIBB: BUSINESS SWOT
  21. CLINQUEST GROUP B.V.: BUSINESS SWOT
  22. COVANCE: BUSINESS SWOT
  23. F. HOFFMANN-LA ROCHE: BUSINESS SWOT
  1. Accenture, Inc.
  2. Bristol-Myers Squibb
  3. Clinquest Group B.V.
  4. Covance
  5. F. Hoffmann-La Roche
  6. GlaxoSmithKline
  7. ICON
  8. iGATE Corporation
  9. iMEDGlobal Corporation
  10. inVentiv Health
  11. Novartis International
  12. PAREXEL International
  13. Pfizer Inc.
  14. Quanticate
  15. Sciformix
360iResearch Logo
Global Pharmacovigilance Market
Report Code: HCNLS-CF420AF | Publishing Date: December 2019 | Number of Pages: 116
cookiefy_close